Pyxis Oncology annual operating margin
2024
2025
Pyxis Oncology Operating Margin Growth & History (PYXS)
Pyxis Oncology's operating margin was −609.18% for fiscal 2025.
View full Pyxis Oncology company overviewPyxis Oncology annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −609.18% | −55.11 pp |
| 2024 | 2024-12-31 | −554.07% | — |
Pyxis Oncology quarterly operating margin
Q1.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | −165.75% | — |
| Q2 2025 | 2025-06-30 | −700.35% | — |
| Q1 2024 | 2024-03-31 | −34.71% | — |
Pyxis Oncology operating margin trends
Between the periods ended 2024-12-31 and 2025-12-31, Pyxis Oncology's operating margin decreased from −554.07% to −609.18%, a change of −55.11 percentage points. The latest reported quarter, Q4 2025, shows −165.75%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pyxis Oncology source filings ↗